Skip to main content
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 2001 Nov-Dec;7(6):1023–1025. doi: 10.3201/eid0706.010618

Vancomycin-intermediate Staphylococcus aureus in a home health-care patient.

J C Hageman 1, D A Pegues 1, C Jepson 1, R L Bell 1, M Guinan 1, K W Ward 1, M D Cohen 1, J A Hindler 1, F C Tenover 1, S K McAllister 1, M E Kellum 1, S K Fridkin 1
PMCID: PMC2631919  PMID: 11747733

Abstract

In June 2000, vancomycin-intermediate Staphylococcus aureus (VISA) was isolated from a 27-year-old home health-care patient following a complicated cholecystectomy. Two VISA strains were identified with identical MICs to all antimicrobials tested except oxacillin and with closely related pulsed-field gel electrophoresis types. The patient was treated successfully with antimicrobial therapy, biliary drainage, and reconstruction. Standard precautions in the home health setting appear successful in preventing transmission.

Full Text

The Full Text of this article is available as a PDF (43.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Centers for Disease Control and Prevention (CDC) Interim guidelines for prevention and control of Staphylococcal infection associated with reduced susceptibility to vancomycin. MMWR Morb Mortal Wkly Rep. 1997 Jul 11;46(27):626-8, 635. [PubMed] [Google Scholar]
  2. Centers for Disease Control and Prevention (CDC) Reduced susceptibility of Staphylococcus aureus to vancomycin--Japan, 1996. MMWR Morb Mortal Wkly Rep. 1997 Jul 11;46(27):624–626. [PubMed] [Google Scholar]
  3. Centers for Disease Control and Prevention (CDC) Staphylococcus aureus with reduced susceptibility to vancomycin--Illinois, 1999. MMWR Morb Mortal Wkly Rep. 2000 Jan 7;48(51-52):1165–1167. [PubMed] [Google Scholar]
  4. Fridkin S. K. Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know. Clin Infect Dis. 2000 Dec 13;32(1):108–115. doi: 10.1086/317542. [DOI] [PubMed] [Google Scholar]
  5. Rotun S. S., McMath V., Schoonmaker D. J., Maupin P. S., Tenover F. C., Hill B. C., Ackman D. M. Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia. Emerg Infect Dis. 1999 Jan-Feb;5(1):147–149. doi: 10.3201/eid0501.990118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Smith T. L., Pearson M. L., Wilcox K. R., Cruz C., Lancaster M. V., Robinson-Dunn B., Tenover F. C., Zervos M. J., Band J. D., White E. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med. 1999 Feb 18;340(7):493–501. doi: 10.1056/NEJM199902183400701. [DOI] [PubMed] [Google Scholar]
  7. Tenover F. C., Arbeit R. D., Goering R. V., Mickelsen P. A., Murray B. E., Persing D. H., Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995 Sep;33(9):2233–2239. doi: 10.1128/jcm.33.9.2233-2239.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Vannuffel P., Gigi J., Ezzedine H., Vandercam B., Delmee M., Wauters G., Gala J. L. Specific detection of methicillin-resistant Staphylococcus species by multiplex PCR. J Clin Microbiol. 1995 Nov;33(11):2864–2867. doi: 10.1128/jcm.33.11.2864-2867.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES